A detailed history of Td Asset Management Inc transactions in Novo Cure LTD stock. As of the latest transaction made, Td Asset Management Inc holds 350,754 shares of NVCR stock, worth $5.91 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
350,754
Previous 294,752 19.0%
Holding current value
$5.91 Million
Previous $5.05 Million 8.58%
% of portfolio
0.01%
Previous 0.0%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

BUY
$15.61 - $23.34 $874,191 - $1.31 Million
56,002 Added 19.0%
350,754 $5.48 Million
Q2 2024

Aug 02, 2024

BUY
$11.83 - $24.05 $156,771 - $318,710
13,252 Added 4.71%
294,752 $5.05 Million
Q1 2024

May 08, 2024

BUY
$12.42 - $17.29 $186,300 - $259,350
15,000 Added 5.63%
281,500 $4.4 Million
Q4 2023

Feb 12, 2024

BUY
$11.13 - $15.78 $627,732 - $889,992
56,400 Added 26.84%
266,500 $3.98 Million
Q3 2023

Oct 27, 2023

SELL
$16.15 - $42.35 $654,850 - $1.72 Million
-40,548 Reduced 16.18%
210,100 $3.39 Million
Q2 2023

Aug 09, 2023

BUY
$40.29 - $82.51 $450,321 - $922,214
11,177 Added 4.67%
250,648 $10.4 Million
Q1 2023

May 10, 2023

BUY
$56.44 - $118.81 $7.35 Million - $15.5 Million
130,291 Added 119.34%
239,471 $14.4 Million
Q4 2022

Feb 06, 2023

SELL
$63.98 - $85.37 $1 Million - $1.34 Million
-15,700 Reduced 12.57%
109,180 $8.01 Million
Q3 2022

Nov 07, 2022

BUY
$67.99 - $89.57 $67,990 - $89,570
1,000 Added 0.81%
124,880 $9.62 Million
Q2 2022

Aug 04, 2022

BUY
$56.6 - $89.9 $860,320 - $1.37 Million
15,200 Added 13.99%
123,880 $8.61 Million
Q1 2022

May 10, 2022

BUY
$60.15 - $84.52 $2.82 Million - $3.96 Million
46,816 Added 75.68%
108,680 $9 Million
Q4 2021

Feb 10, 2022

BUY
$75.08 - $121.99 $383,358 - $622,880
5,106 Added 9.0%
61,864 $4.65 Million
Q3 2021

Nov 09, 2021

SELL
$116.17 - $194.55 $205,620 - $344,353
-1,770 Reduced 3.02%
56,758 $6.59 Million
Q2 2021

Aug 11, 2021

BUY
$130.4 - $225.58 $2.64 Million - $4.57 Million
20,248 Added 52.89%
58,528 $9.01 Million
Q1 2021

May 14, 2021

SELL
$124.11 - $190.17 $58,455 - $89,570
-471 Reduced 1.22%
38,280 $5.06 Million
Q4 2020

Feb 16, 2021

BUY
$112.16 - $174.14 $1.1 Million - $1.71 Million
9,791 Added 33.81%
38,751 $6.71 Million
Q3 2020

Nov 10, 2020

BUY
$58.05 - $111.31 $81,270 - $155,834
1,400 Added 5.08%
28,960 $3.22 Million
Q2 2020

Aug 13, 2020

BUY
$57.2 - $74.41 $22,880 - $29,764
400 Added 1.47%
27,560 $1.63 Million
Q1 2020

May 15, 2020

SELL
$57.05 - $95.75 $205,380 - $344,700
-3,600 Reduced 11.7%
27,160 $1.83 Million
Q4 2019

Feb 11, 2020

SELL
$68.3 - $93.8 $928,880 - $1.28 Million
-13,600 Reduced 30.66%
30,760 $2.59 Million
Q3 2019

Nov 07, 2019

SELL
$61.86 - $97.8 $2.25 Million - $3.56 Million
-36,400 Reduced 45.07%
44,360 $3.32 Million
Q2 2019

Aug 01, 2019

BUY
$42.22 - $63.23 $859,599 - $1.29 Million
20,360 Added 33.71%
80,760 $5.11 Million
Q1 2019

May 08, 2019

BUY
$31.96 - $56.12 $134,232 - $235,704
4,200 Added 7.47%
60,400 $2.91 Million
Q4 2018

Feb 01, 2019

BUY
$28.72 - $52.63 $1.61 Million - $2.96 Million
56,200 New
56,200 $1.88 Million

Others Institutions Holding NVCR

About NovoCure Ltd


  • Ticker NVCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 104,950,000
  • Market Cap $1.77B
  • Description
  • NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...
More about NVCR
Track This Portfolio

Track Td Asset Management Inc Portfolio

Follow Td Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Td Asset Management Inc with notifications on news.